SYRE vs RYTM

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 11, 2026

SYRE

32.7
AI Score
VS
SYRE Wins

RYTM

29.0
AI Score

Investment Advisor Scores

SYRE

33score
Recommendation
EXTENDED

RYTM

29score
Recommendation
AVOID NEW MONEY

AI Analyst Insights

Detailed Metrics Comparison

Metric SYRE RYTM Winner
Forward P/E 0 333.3333 Tie
PEG Ratio 0 0 Tie
Revenue Growth 0.0% 79.6% RYTM
Earnings Growth -99.7% 0.0% RYTM
Tradestie Score 32.7/100 29.0/100 SYRE
Profit Margin 0.0% -69.0% SYRE
Beta 1.00 1.00 Tie
AI Recommendation EXTENDED AVOID NEW MONEY SYRE

Relative Price Performance (Last 90 Days)

SYRE 1M: +32.8% · 3M: +4.9% RYTM 1M: +29.5% · 3M: -3.3%

Current Technical Phase

SYRE

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 64

RSI (14): 64.2 · Price: $106.82

RYTM

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 66

RSI (14): 65.5 · Price: $112.16

Fundamentals Snapshot

Metric SYRE RYTM
Market Cap — —
Forward P/E -28.9 -86.4
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth 0.0% 0.8%
Gross Margin — 0.9%
Operating Margin 0.0% -0.7%
EPS -2.39 -2.91
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, SYRE is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.